Lipid-Lowering
Pregnancy: X — contraindicated
Atorvastatin
Brand names: Lipitor
Adult dose
Dose: Primary prevention: 20mg OD. Secondary prevention / high risk: 40–80mg OD
Route: Oral
Frequency: Once daily (any time — long half-life)
Max: 80mg/day
NICE recommends 20mg OD for primary prevention (10-year CVD risk ≥10%). 40–80mg OD for established CVD, diabetes with end-organ damage, CKD, or familial hypercholesterolaemia.
Dose adjustments
Renal
No dose adjustment required.
Hepatic
Contraindicated in active liver disease or unexplained persistent elevated transaminases.
Clinical pearls
- Atorvastatin has a long half-life (~14h) — timing of dose is flexible, unlike some other statins (e.g. simvastatin, best taken at night).
- Muscle symptoms: check CK. If CK <10× ULN and mild symptoms, can continue with monitoring. If CK >10× ULN or rhabdomyolysis suspected, stop immediately.
- HPS trial: simvastatin 40mg vs placebo — 33% reduction in CV events regardless of baseline LDL. Applies to atorvastatin class.
- JUPITER trial: rosuvastatin 20mg in patients with elevated CRP even with normal LDL — 44% CV event reduction.
- Aim for LDL cholesterol <1.8 mmol/L (secondary prevention) or <2.0 mmol/L (primary prevention, high risk).
Contraindications
- Active liver disease or unexplained persistent elevated transaminases
- Pregnancy and breastfeeding
- Concomitant ciclosporin (risk of severe myopathy)
Side effects
- Muscle pain / myalgia (most common — 5–10%)
- Myopathy / rhabdomyolysis (rare — particularly with interactions)
- Elevated transaminases (usually transient and benign — <3× ULN acceptable)
- New-onset diabetes (modest risk — NNH ~255)
- GI disturbance: nausea, constipation, flatulence
- Headache
Interactions
- Clarithromycin / erythromycin (CYP3A4 inhibitors): increase statin levels — suspend statin during short course
- Amiodarone: increased statin levels
- Fibrates (gemfibrozil): increased myopathy risk — avoid combination
- Ciclosporin: significantly increases statin levels — contraindicated
- Grapefruit juice: modest increase in atorvastatin levels
Monitoring
- Lipid profile at 3 months (aim ≥40% LDL reduction). LFTs before and if symptomatic. CK only if myalgia present.
Reference: NICE NG238 Lipid Modification; HPS Trial Lancet 2002; NICE BNF 84. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
Pathways
- Acute Heart Failure · ESC 2021 Heart Failure Guidelines; NICE NG106
- NSTEMI / Unstable Angina · ESC 2020 NSTEMI Guidelines; NICE NG185
- New-Onset Atrial Fibrillation · ESC 2020 AF Guidelines; NICE NG196
- Hypertensive Emergency · ESC/ESH 2018 Hypertension Guidelines; NICE NG136
- Bradycardia Management · Resuscitation Council UK ABCDE; ESC 2021 Pacing Guidelines
- Ventricular Tachycardia / Fibrillation · Resuscitation Council UK ACLS; ESC 2022 Ventricular Arrhythmia Guidelines